• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的戒烟经济评估及其在新环境中的可转移性:一项系统综述。

Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.

作者信息

Berg Marrit L, Cheung Kei Long, Hiligsmann Mickaël, Evers Silvia, de Kinderen Reina J A, Kulchaitanaroaj Puttarin, Pokhrel Subhash

机构信息

Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.

出版信息

Addiction. 2017 Jun;112(6):946-967. doi: 10.1111/add.13748. Epub 2017 Feb 15.

DOI:10.1111/add.13748
PMID:28060453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5434798/
Abstract

AIMS

To identify different types of models used in economic evaluations of smoking cessation, analyse the quality of the included models examining their attributes and ascertain their transferability to a new context.

METHODS

A systematic review of the literature on the economic evaluation of smoking cessation interventions published between 1996 and April 2015, identified via Medline, EMBASE, National Health Service (NHS) Economic Evaluation Database (NHS EED), Health Technology Assessment (HTA). The checklist-based quality of the included studies and transferability scores was based on the European Network of Health Economic Evaluation Databases (EURONHEED) criteria. Studies that were not in smoking cessation, not original research, not a model-based economic evaluation, that did not consider adult population and not from a high-income country were excluded.

FINDINGS

Among the 64 economic evaluations included in the review, the state-transition Markov model was the most frequently used method (n = 30/64), with quality adjusted life years (QALY) being the most frequently used outcome measure in a life-time horizon. A small number of the included studies (13 of 64) were eligible for EURONHEED transferability checklist. The overall transferability scores ranged from 0.50 to 0.97, with an average score of 0.75. The average score per section was 0.69 (range = 0.35-0.92). The relative transferability of the studies could not be established due to a limitation present in the EURONHEED method.

CONCLUSION

All existing economic evaluations in smoking cessation lack in one or more key study attributes necessary to be fully transferable to a new context.

摘要

目的

识别戒烟经济评估中使用的不同类型模型,分析纳入模型的质量,考察其属性,并确定其向新环境的可转移性。

方法

通过Medline、EMBASE、英国国家医疗服务体系(NHS)经济评估数据库(NHS EED)、卫生技术评估(HTA)对1996年至2015年4月发表的关于戒烟干预经济评估的文献进行系统综述。纳入研究基于清单的质量和可转移性得分基于欧洲卫生经济评估数据库网络(EURONHEED)标准。排除非戒烟研究、非原创研究、非基于模型的经济评估、未考虑成年人群以及非来自高收入国家的研究。

结果

在综述纳入的64项经济评估中,状态转换马尔可夫模型是最常用的方法(n = 30/64),在终身视角下,质量调整生命年(QALY)是最常用的结果指标。纳入研究中少数(64项中的13项)符合EURONHEED可转移性清单标准。总体可转移性得分范围为0.50至0.97,平均得分为0.75。各部分平均得分0.69(范围 = 0.35 - 0.92)。由于EURONHEED方法存在局限性,无法确定这些研究的相对可转移性。

结论

所有现有的戒烟经济评估都缺乏一项或多项完全转移到新环境所需的关键研究属性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3856/5434798/ba5ebe6a4bc7/ADD-112-946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3856/5434798/b2568f9c093d/ADD-112-946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3856/5434798/ba5ebe6a4bc7/ADD-112-946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3856/5434798/b2568f9c093d/ADD-112-946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3856/5434798/ba5ebe6a4bc7/ADD-112-946-g002.jpg

相似文献

1
Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.基于模型的戒烟经济评估及其在新环境中的可转移性:一项系统综述。
Addiction. 2017 Jun;112(6):946-967. doi: 10.1111/add.13748. Epub 2017 Feb 15.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
7
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
8
Behavioural interventions for smoking cessation: an overview and network meta-analysis.行为干预戒烟:综述和网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2.
9
'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.使用尼古丁替代疗法“减量戒烟”:有效性的系统评价与经济分析
Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. doi: 10.3310/hta12020.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications.术前戒烟干预预防手术并发症的经济评价系统评价议定书。
BMJ Open. 2021 Nov 16;11(11):e057171. doi: 10.1136/bmjopen-2021-057171.
2
Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.精神障碍患者戒烟干预措施的长期成本效益:动态决策分析模型
Value Health. 2021 Sep;24(9):1263-1272. doi: 10.1016/j.jval.2021.04.002. Epub 2021 Jun 3.
3
What is the likely impact on surgical site infections in Australian hospitals if smoking rates are reduced? A cost analysis.

本文引用的文献

1
Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.五个欧洲国家利益相关者对使用卫生技术评估(HTA)信息的意见异同:EQUIPT调查结果
Health Res Policy Syst. 2016 May 26;14(1):38. doi: 10.1186/s12961-016-0110-7.
2
Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation.伐尼克兰初始戒烟治疗失败或复发后再治疗的成本效益
Prev Med Rep. 2015 Mar 14;2:189-95. doi: 10.1016/j.pmedr.2015.03.004. eCollection 2015.
3
如果降低澳大利亚医院的吸烟率,对手术部位感染可能会产生什么影响?一项成本分析。
PLoS One. 2021 Aug 25;16(8):e0256424. doi: 10.1371/journal.pone.0256424. eCollection 2021.
4
Tobacco Control Policy Simulation Models: Protocol for a Systematic Methodological Review.烟草控制政策模拟模型:系统方法学综述方案
JMIR Res Protoc. 2021 Jul 26;10(7):e26854. doi: 10.2196/26854.
5
Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations.为亚洲的政策制定者提供有关人群层面烟草控制干预措施效率的信息:基于模型的经济评估的系统评价。
J Glob Health. 2020 Dec;10(2):020437. doi: 10.7189/jogh.10.020437.
6
Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan.运用成本效益分析支持政策变革:约旦使用伐尼克兰和尼古丁替代疗法戒烟的情况
J Pharm Policy Pract. 2020 Oct 27;13:65. doi: 10.1186/s40545-020-00270-y. eCollection 2020.
7
Alcohol consumption's attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models.饮酒导致的疾病负担及其与有针对性的公共卫生干预措施的成本效益:系统综述数学模型。
BMC Public Health. 2019 Oct 26;19(1):1378. doi: 10.1186/s12889-019-7771-4.
8
Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up.在牙科环境中高强度与低强度戒烟干预措施的成本效益比较:长期随访。
BMJ Open. 2019 Aug 15;9(8):e030934. doi: 10.1136/bmjopen-2019-030934.
9
Smoking Cessation: A Comparison of Two Model Structures.戒烟:两种模型结构的比较。
Pharmacoeconomics. 2018 Sep;36(9):1101-1112. doi: 10.1007/s40273-018-0657-y.
10
Estimates of costs for modelling return on investment from smoking cessation interventions.估算戒烟干预措施投资回报率模型的成本。
Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):32-41. doi: 10.1111/add.14091. Epub 2018 Mar 13.
Understanding the stakeholders' intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool.
了解利益相关者使用经济决策支持工具的意图:一项关于烟草投资回报率工具的横断面研究。
Health Policy. 2016 Jan;120(1):46-54. doi: 10.1016/j.healthpol.2015.11.004. Epub 2015 Nov 28.
4
Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.针对医生和药剂师的戒烟咨询培训的成本效益分析。
Addict Behav. 2015 Jun;45:79-86. doi: 10.1016/j.addbeh.2015.01.004. Epub 2015 Jan 14.
5
A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease.一项对马尔可夫模型得出的质量和成本效益的系统评价,该模型评估了慢性阻塞性肺疾病患者的戒烟干预措施。
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):301-16. doi: 10.1586/14737167.2015.1001976. Epub 2015 Jan 20.
6
A cost-effectiveness analysis of the first federally funded antismoking campaign.首次联邦资助的反吸烟运动的成本效益分析。
Am J Prev Med. 2015 Mar;48(3):318-25. doi: 10.1016/j.amepre.2014.10.011. Epub 2014 Dec 10.
7
EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control.EQUIPT:一项比较效果研究的方案,评估烟草控制经济证据的跨背景可转移性。
BMJ Open. 2014 Nov 24;4(11):e006945. doi: 10.1136/bmjopen-2014-006945.
8
Economic evaluation of interventions in health care.医疗保健干预措施的经济评估。
Nurs Stand. 2014 Nov 11;29(10):49-58. doi: 10.7748/ns.29.10.49.e9315.
9
Potential transferability of economic evaluations of programs encouraging physical activity in children and adolescents across different countries--a systematic review of the literature.鼓励儿童和青少年进行体育活动项目的经济评估在不同国家间的潜在可转移性——文献系统综述
Int J Environ Res Public Health. 2014 Oct 15;11(10):10606-21. doi: 10.3390/ijerph111010606.
10
The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.伐尼克兰(12周标准疗程和12 + 12周延长疗程)与加拿大其他戒烟策略相比的长期成本效益。
Int J Clin Pract. 2014 May;68(5):639-46. doi: 10.1111/ijcp.12363. Epub 2014 Jan 29.